Table 1

Risk factors affecting outcome of treatment of patients with Hodgkin lymphoma that are intrinsic to the patient

Risk factorFrequency, %5-y OS, %PReference
Age 27, 33, 38-42, 111-117 
 >45 y 34 96 vs 77 <.0001  
 >60 y 18 95 vs 64 <.0001  
 >79 y 91 vs 34 <.0001  
Male gender 55 91 vs 88 .018 27, 33, 39-42 
HIV infection 1.2 89 vs 41 <.0001 16, 17, 20-27 
Prior reduced lung function, major 5-10 * Not applicable BCCA “experience” 
Prior reduced cardiac function 5-10 * Not applicable BCCA “experience” 
Risk factorFrequency, %5-y OS, %PReference
Age 27, 33, 38-42, 111-117 
 >45 y 34 96 vs 77 <.0001  
 >60 y 18 95 vs 64 <.0001  
 >79 y 91 vs 34 <.0001  
Male gender 55 91 vs 88 .018 27, 33, 39-42 
HIV infection 1.2 89 vs 41 <.0001 16, 17, 20-27 
Prior reduced lung function, major 5-10 * Not applicable BCCA “experience” 
Prior reduced cardiac function 5-10 * Not applicable BCCA “experience” 

Frequency with which the risk factor was encountered and single-variable impact (5-year OS; % absent vs % present) in a large sample (n = 1443) of consecutively diagnosed, unselected patients with Hodgkin lymphoma in British Columbia between 1998 and 2013. Note: a steady improvement in overall survival has occurred across this time interval.

BCCA, British Columbia Cancer Agency; OS, overall survival.

*

Presence of these risk factors reduces OS by ∼20% (hazard rate for overall survival: ∼0.75).

Close Modal

or Create an Account

Close Modal
Close Modal